LEON Nanodrugs GmbH is a pharmaceutical company specializing in the development of nanoparticle-based drug formulations. Based in Planegg, Germany, the company addresses challenges in drug development, particularly in achieving reproducibility, quality control, and scaling manufacturing processes. Their innovative FR-JET technology utilizes high-velocity fluid mixing to create homogeneous nanoparticles, enhancing product consistency and reducing batch-to-batch variability. LEON focuses on providing solutions for complex drug modalities, ensuring compliance with Good Manufacturing Practices (GMP). The company’s approach combines advanced engineering with a commitment to improving drug delivery systems for better therapeutic outcomes.